RCMI Coordinating Center (RCMI CC) Header Logo

Connection

Eddy Ríos-Olivares to Male

This is a "connection" page, showing publications Eddy Ríos-Olivares has written about Male.
Connection Strength

0.330
  1. Maldonado-Mart?nez G, Hunter-Mellado RF, Fern?ndez-Santos D, R?os-Olivares E. Persistent HIV Viremia: Description of a Cohort of HIV Infected Individuals with ART Failure in Puerto Rico. Int J Environ Res Public Health. 2015 Dec 22; 13(1):ijerph13010050.
    View in: PubMed
    Score: 0.035
  2. Cubano LA, Cumba L, del Sep?lveda-Torres LC, Boukli N, R?os-Olivares E. Prevalence of drug resistance and associated mutations in a population of Hiv-1+ Puerto Ricans in 2005. Bol Asoc Med P R. 2010 Jul-Sep; 102(3):13-7.
    View in: PubMed
    Score: 0.024
  3. R?os G, Mayor AM. Clinical and sociodemographic features of Puerto Ricans with systemic sclerosis. Ethn Dis. 2010; 20(1 Suppl 1):S1-185-9.
    View in: PubMed
    Score: 0.023
  4. Colon HM, Finlinson HA, Negron J, Sosa I, Rios-Olivares E, Robles RR. Pilot trial of an intervention aimed at modifying drug preparation practices among injection drug users in Puerto Rico. AIDS Behav. 2009 Jun; 13(3):523-31.
    View in: PubMed
    Score: 0.022
  5. Delgado-V?lez M, Lugo-Chinchilla A, Lizardo L, Morales I, Robles Y, Bruno N, Rodr?guez JW, R?os-Olivares E, Correa M, Renaud FL. Chronic exposure of human macrophages in vitro to morphine and methadone induces a putative tolerant/dependent state. J Neuroimmunol. 2008 May 30; 196(1-2):94-100.
    View in: PubMed
    Score: 0.021
  6. Cubano LA, Sep?lveda-Torres Ldel C, Sosa G, Boukli N, Robles R, Rodriguez JW, Guzm?n L, R?os-Olivares E. Prevalence of drug resistance and associated mutations in HIV-positive Puerto Ricans: sex variations. Ethn Dis. 2008; 18(2 Suppl 2):S2-132-6.
    View in: PubMed
    Score: 0.020
  7. R?os-Olivares E, Vil? LM, Reyes JC, Rodr?guez JW, Col?n JH, Pag?n NO, Marrero A, R?os-Orraca ZM, Boukli NM, Shapshak P, Robles RR. Impaired cytokine production and suppressed lymphocyte proliferation activity in HCV-infected cocaine and heroin ("speedball") users. Drug Alcohol Depend. 2006 Dec 01; 85(3):236-43.
    View in: PubMed
    Score: 0.019
  8. Reyes JC, Col?n HM, Robles RR, Rios E, Matos TD, Negr?n J, Marrero CA, Calder?n JM, Shepard E. Prevalence and correlates of hepatitis C virus infection among street-recruited injection drug users in San Juan, Puerto Rico. J Urban Health. 2006 Nov; 83(6):1105-13.
    View in: PubMed
    Score: 0.019
  9. Vil? LM, Molina MJ, Mayor AM, Cruz JJ, R?os-Olivares E, R?os Z. Association of serum MIP-1alpha, MIP-1beta, and RANTES with clinical manifestations, disease activity, and damage accrual in systemic lupus erythematosus. Clin Rheumatol. 2007 May; 26(5):718-22.
    View in: PubMed
    Score: 0.019
  10. Roman M, Rodriguez JW, Pag?n NO, Rios-Olivares E, Amill A, Hunter R. Distribution of na?ve (CD45RA+) and memory (CD45RO+) T-cells in HIV-infected Puerto Rican population. P R Health Sci J. 2002 Sep; 21(3):195-201.
    View in: PubMed
    Score: 0.014
  11. R?os-Olivares E, Yamamura Y, G?mez MA, Guzm?n L, Rodr?guez N, Fern?ndez D, Hunter Mellado R. HCV genotype analysis in HCV-HIV-co-infected Puerto Ricans who are injecting drug users: undetermined and mixed infections. Cell Mol Biol (Noisy-le-grand). 2001 Sep; 47(6):1017-24.
    View in: PubMed
    Score: 0.013
  12. Fern?ndez DM, Figueroa WI, G?mez Mde L, Maysonet J, Olivares ER, Hunter RF. Changes in HIV/AIDS knowledge among early adolescents in Puerto Rico. Ethn Dis. 2008; 18(2 Suppl 2):S2-146-50.
    View in: PubMed
    Score: 0.010
  13. Sep?lveda-Torres LDC, Rishishwar L, Rogers ML, R?os-Olivares E, Boukli N, Jordan IK, Cubano LA. A decade of viral mutations and associated drug resistance in a population of HIV-1+ Puerto Ricans: 2002-2011. PLoS One. 2017; 12(5):e0177452.
    View in: PubMed
    Score: 0.010
  14. Fernandez-Santos DM, Miranda-Diaz C, Figueroa-Cosme WI, Ramon RO, Mayor AM, Rios-Olivares E, Hunter-Mellado RF. Impact of ASUMA Intervention on HIV Risk Behaviors among Puerto Rican Adolescents. Int J Environ Res Public Health. 2015 Dec 23; 13(1):ijerph13010060.
    View in: PubMed
    Score: 0.009
  15. Ortiz AP, Reyes JC, Palefsky J, Negr?n J, Da Costa M, V?zquez M, Rivera AI, Matos TD, Rios-Olivares E, Tortolero G. Oral human papillomavirus infection among drug users in Puerto Rico. P R Health Sci J. 2014 Dec; 33(4):190-6.
    View in: PubMed
    Score: 0.008
  16. Maldonado-Mart?nez G, Fern?ndez-Santos DM, R?os-Olivares E, Mayor AM, Hunter-Mellado RF. HIV/AIDS in the Puerto Rican elderly: immunological changes between gender and body mass index. J Health Care Poor Underserved. 2013 Nov; 24(4 Suppl):94-105.
    View in: PubMed
    Score: 0.008
  17. Mayor AM, Fern?ndez Santos DM, Dworkin MS, R?os-Olivares E, Hunter-Mellado RF. Toxoplasmic encephalitis in an AIDS cohort at Puerto Rico before and after highly active antiretroviral therapy (HAART). Am J Trop Med Hyg. 2011 May; 84(5):838-41.
    View in: PubMed
    Score: 0.006
  18. Fern?ndez Santos DM, Figueroa-Cosme WI, G?mez Mde L, Maysonet-Cruz J, Miranda-D?az C, Sept?lveda-Santiago M, R?os-Olivares E, Hunter-Mellado RF. Changes in developmental factors and HIV risk behaviors among early adolescents in Puerto Rico. Ethn Dis. 2010; 20(1 Suppl 1):S1-122-6.
    View in: PubMed
    Score: 0.006
  19. Mayor AM, Dworkin M, Quesada L, R?os-Olivares E, Hunter-Mellado RF. The morbidity and mortality associated with kidney disease in an HIV-infected cohort in Puerto Rico. Ethn Dis. 2010; 20(1 Suppl 1):S1-163-7.
    View in: PubMed
    Score: 0.006
  20. B?ez Feliciano DV, G?mez MA, Fern?ndez-Santos DM, Quintana R, Rios-Olivares E, Hunter-Mellado RF. Profile of Puerto Rican HIV/AIDS patients with early and non-early initiation of injection drug use. Ethn Dis. 2008; 18(2 Suppl 2):S2-99-104.
    View in: PubMed
    Score: 0.005
  21. Mayor AM, G?mez MA, R?os-Olivares E, Hunter-Mellado RF. AIDS-defining neoplasm prevalence in a cohort of HIV-infected patients, before and after highly active antiretroviral therapy. Ethn Dis. 2008; 18(2 Suppl 2):S2-189-94.
    View in: PubMed
    Score: 0.005
  22. Mayor AM, Gomez MA, Fernandez DM, Rios-Olivares E, Thomas JC, Hunter RF. Morbidity and mortality profile of human immunodeficiency virus-infected patients with and without hepatitis C co-infection. Am J Trop Med Hyg. 2006 Feb; 74(2):239-45.
    View in: PubMed
    Score: 0.004
  23. B?ez-Feliciano DV, Thomas JC, G?mez MA, Miranda S, Fern?ndez DM, Vel?zquez M, R?os-Olivares E, Hunter-Mellado RF. Changes in the AIDS epidemiologic situation in Puerto Rico following health care reform and the introduction of HAART. Rev Panam Salud Publica. 2005 Feb; 17(2):92-101.
    View in: PubMed
    Score: 0.004
  24. Mayor AM, G?mez MA, R?os-Oliveras E, Hunter-Mellado RF. Mortality trends of HIV-infected patients after the introduction of highly active antiretroviral therapy: analysis of a cohort of 3,322 HIV-infected persons. Ethn Dis. 2005; 15(4 Suppl 5):S5-57-62.
    View in: PubMed
    Score: 0.004
  25. Fern?ndez DM, G?mez Mde L, Figueroa W, Vel?zquez M, B?ez DV, R?os-Olivares E, Hunter RF. A comparison of the sociodemographic, risk-behavior, and substance-abuse profile of young vs older HIV-infected Puerto Rican patients. Ethn Dis. 2005; 15(4 Suppl 5):S5-25-9.
    View in: PubMed
    Score: 0.004
  26. Mayor AM, Gomez MA, Rios E, Hunter RF. Recurrent pneumonia mortality risk in a HIV/AIDS Puerto Rican cohort. Cell Mol Biol (Noisy-le-grand). 2003 Dec; 49(8):1199-204.
    View in: PubMed
    Score: 0.004
  27. Vil? LM, R?os-Olivares E, R?os Z, Mel?ndez M, Garc?a M, Pichardo B. Abnormal immunological response to Mycobacterium tuberculosis antigens in a patient with chronic myelocytic leukemia and active tuberculosis. P R Health Sci J. 1998 Dec; 17(4):345-52.
    View in: PubMed
    Score: 0.003
  28. Vila LM, R?os-Olivares E, Vila S, R?os Z, Rivera E, Robles R, Reyes JC, Castillo X. Correlation of the suppressive activity of a biological response modifier on the proliferation of peripheral blood mononuclear cells and the reduction of HIV titer. Cell Mol Biol (Noisy-le-grand). 1997 Nov; 43(7):981-8.
    View in: PubMed
    Score: 0.003
  29. Kaplan JE, Yamamura Y, R?os-Olivares EO, Cannon RO, Khabbaz RF, Gubler DJ, Kaiselburd EN, Hartley TM, Lairmore MD. Seroprevalence of human T lymphotropic virus type I in Puerto Rico. Am J Trop Med Hyg. 1989 Jun; 40(6):659-62.
    View in: PubMed
    Score: 0.001
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support